Vedaclidine 是一种口服有效的混合受体活性毒蕈碱型乙酰胆碱受体 (mAChR) 调节剂,可激活毒蕈碱 M2 和 M4 受体并阻断毒蕈碱 M1、M3 和 M5 受体,通过作用于脊髓 M4 毒蕈碱受体发挥活性且不诱导体温过低或过度流涎,可用于疼痛、神经性疼痛及炎症性疼痛状态的相关研究。
产品编号: MS-Q79490 CAS No.: 141575-50-0 分子式: C13H21N3S2 分子量: 283.46
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

Vedaclidine 是一种口服有效的混合受体活性毒蕈碱型乙酰胆碱受体 (mAChR) 调节剂,可激活毒蕈碱 M2 和 M4 受体并阻断毒蕈碱 M1、M3 和 M5 受体,通过作用于脊髓 M4 毒蕈碱受体发挥活性且不诱导体温过低或过度流涎,可用于疼痛、神经性疼痛及炎症性疼痛状态的相关研究。

生物实验数据

生物活性 Vedaclidine is an orally active muscarinic acetylcholine receptor (mAChR) modulator with mixed receptor activity that activates muscarinic M2 and M4 receptors and blocks muscarinic M1, M3, and M5 receptors, exerts its activity through interaction with spinal M4 muscarinic receptors without inducing hypothermia or excessive salivation, and can be used in research related to pain, neuropathic pain, and inflammatory pain states.
IC50 & Target

mAChR1

 

mAChR2

 

mAChR3

 

mAChR4

 

mAChR5

 

体内研究
(In Vivo)

Vedaclidine (0.3-10 mg/kg;口服;单次给药) 在福尔马林诱导的疼痛模型中产生剂量依赖性的抗痛觉过敏作用。
Vedaclidine (0.3-10 mg/kg;皮下注射;单次给药) 可呈剂量依赖性逆转辣椒素诱导的机械性痛觉过敏。
Vedaclidine (0.1-30 mg/kg;皮下注射;单次给药) 可通过激活毒蕈碱受体,呈剂量依赖性逆转角叉菜胶诱导的热痛觉过敏和机械痛觉过敏,且与 Ketoprofen (MS-Q27925) 联用表现出协同镇痛作用。
Vedaclidine (1.0-10 mg/kg;口服;皮下注射;单次给药) 在剂量高达 10 mg/kg 口服或皮下注射时,不会损害转棒试验中的运动表现。

Animal Model: Sprague-Dawley (adult male, 200-250 g)
Dosage: 0.3 mg/kg; 1.0 mg/kg; 3.0 mg/kg; 10 mg/kg
Administration: p.o.; single dose
Result: Produced a dose-dependent reduction in formalin-induced paw licking.
Significantly reduced licking time in the early phase (0-5 minutes) at 10 mg/kg.
Significantly reduced licking time in the late phase (15-40 minutes) at 3.0 mg/kg and 10 mg/kg.
Animal Model: Sprague-Dawley (adult male, 250-300 g)
Dosage: 0.3 mg/kg; 1.0 mg/kg; 3.0 mg/kg; 10 mg/kg
Administration: s.c.; single dose
Result: Produced a dose-related reversal of capsaicin-induced mechanical hyperalgesia.
Significantly increased withdrawal thresholds at 3.0 mg/kg and 10 mg/kg.
Restored withdrawal thresholds to the maximum non-capsaicin injected level (~15 g) at 10 mg/kg.
Animal Model: Sprague-Dawley (adult male, 80-100 g)
Dosage: 0.1 mg/kg; 0.3 mg/kg; 1.0 mg/kg; 3.0 mg/kg; 10 mg/kg; 30 mg/kg; 1.0 mg/kg (scopolamine combination)
Administration: s.c.; single dose
Result: Produced a dose-related reversal of carrageenan-induced thermal hyperalgesia, with significant effects at 0.3 mg/kg and higher.
Shifted the vedaclidine dose-response curve ~10-fold right for thermal hyperalgesia reversal when combined with 1.0 mg/kg s.c. scopolamine.
Produced a dose-related reversal of carrageenan-induced mechanical allodynia, with significant effects at 3.0-30 mg/kg.
Caused a modest right shift of the mechanical allodynia dose-response curve when combined with scopolamine.
Exhibited synergistic anti-thermal hyperalgesic effects with ketoprofen at fixed dose-ratios of 1:5, 1:10, and 1:30.
Had an ED50 of 0.45 mg/kg s.c. for thermal hyperalgesia reversal alone.
Demonstrated combination doses effective at levels inactive when administered alone.
Animal Model: Sprague-Dawley (adult male, 200-250 g; 250-300 g)
Dosage: 1.0 mg/kg; 3.0 mg/kg; 10 mg/kg
Administration: p.o.; single dose; s.c.; single dose
Result: Produced no significant effect on rotarod performance up to 2 hours post-administration at any tested dose via p.o. or s.c. routes.

化学信息

分子量 283.46
分子式 C13H21N3S2
CAS No. 141575-50-0

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础